John E. (Jack) Bailey Jr. G1 Therapeutics, Inc. (GTHX) insider trading activity

GTHX Quotes by TradingView

John E. (Jack) Bailey Jr. is President and CEO of G1 Therapeutics, Inc.. Currently has a direct ownership of 557,336 shares of GTHX, which is worth approximately $1.43 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 105,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 557K
13.84% 3M change
28.55% 12M change
Total Value Held $1.43 Million

John E. (Jack) Bailey Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Grant, award, or other acquisition
-
105,000 Added 15.85%
557,336 Common Stock
May 13 2024
SELL
Open market or private sale
$178,465 $4.79 p/Share
37,258 Reduced 7.61%
452,336 Common Stock
Jan 03 2024
SELL
Open market or private sale
$36,460 $3.12 p/Share
11,686 Reduced 2.33%
489,594 Common Stock
Jan 03 2024
BUY
Grant, award, or other acquisition
-
100,700 Added 16.73%
501,280 Common Stock
Jan 02 2024
SELL
Open market or private sale
$107,854 $3.27 p/Share
32,983 Reduced 7.61%
400,580 Common Stock
Jul 05 2023
SELL
Open market or private sale
$6,661 $2.45 p/Share
2,719 Reduced 0.62%
433,563 Common Stock
May 10 2023
BUY
Grant, award, or other acquisition
-
160,000 Added 26.83%
436,282 Common Stock
Jan 04 2023
SELL
Open market or private sale
$31,287 $5.58 p/Share
5,607 Reduced 1.99%
276,282 Common Stock
Jan 03 2023
SELL
Open market or private sale
$187,311 $5.85 p/Share
32,019 Reduced 10.2%
281,889 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
80,700 Added 20.45%
313,908 Common Stock
Jan 03 2022
SELL
Open market or private sale
$355,241 $10.41 p/Share
34,125 Reduced 12.76%
233,208 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
46,000 Added 14.68%
267,333 Common Stock
Jan 01 2021
BUY
Grant, award, or other acquisition
-
213,333 Added 49.08%
221,333 Common Stock
Nov 11 2020
BUY
Open market or private purchase
$51,320 $12.83 p/Share
4,000 Added 33.33%
8,000 Common Stock
Nov 10 2020
BUY
Open market or private purchase
$51,040 $12.76 p/Share
4,000 Added 50.0%
4,000 Common Stock
JE(

John E. (Jack) Bailey Jr.

President and CEO
Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTHX